You just read:

BioLineRx Discloses Positive Correlative Data from Phase 2a AML Study and Mechanism-of-Action Data for BL-8040 Oncology Platform at ASH 2016

News provided by

BioLineRx Ltd.

03 Nov, 2016, 09:00 ET